Astellas Venture Management LLC

	Country	Date	Notes
Mission Bay Capital III		16 Sep 2019	Fund Closing Active
Cleave Biosciences Inc Drug development company focused on novel targets in cellular protein homeostasis pathways	United States	1 Oct 2011	Series A Active
Fate Therapeutics Inc	United States	1 Nov 2009	Series B Initial investment. Round participant. Active
Nereus Pharmaceuticals Inc	United States	1 Aug 2007	Series D
DecImmune Therapeutics Inc Developer of antibodies to reduce tissue damage and improve ventricular function associated with myocardial infarction	United States		N/A
Cellzome AG A drug discovery and development company and a leader in the use of chemical proteomics technologies.	Germany		N/A Active
Renovar Inc	United States		N/A
Adhelex Technologies	Canada		N/A Active
Epizyme Inc Focusing on the discovery and development of innovative drugs targeting epigenetic enzymes, in particular histone methyltransferases (HMTs).	United States		N/A
Evolva Holding SA	Switzerland		N/A
Revivicor Inc	United States		N/A
Ironwood Pharmaceuticals Inc Entrepreneurial pharmaceutical company, engages in developing and marketing human medicines.	United States		N/A
F2G Ltd	United Kingdom		N/A
CoMentis Inc	United States		N/A
Intradigm Corp	United States		N/A
PhaseBio Pharmaceuticals Inc	United States		N/A
Plexxikon Inc	United States		N/A
AkaRx Inc	United States		N/A Active
Inimex Pharmaceuticals Inc	Canada		N/A
FASgen Inc	United States		N/A

Analytics